Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
28.76
-0.74 (-2.51%)
Oct 8, 2025, 4:00 PM EDT - Market closed

Rigel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
516296253259453591
Upgrade
Market Cap Growth
113.08%17.18%-2.48%-42.79%-23.38%64.89%
Upgrade
Enterprise Value
469335295269403560
Upgrade
Last Close Price
28.7616.8214.5015.0026.5035.00
Upgrade
PE Ratio
5.2916.95----
Upgrade
Forward PE
11.6517.39----
Upgrade
PS Ratio
1.901.652.182.243.275.45
Upgrade
PB Ratio
6.3090.11-8.83-19.0414.9217.38
Upgrade
P/TBV Ratio
9.21---14.9217.38
Upgrade
P/FCF Ratio
7.849.43--86.30-
Upgrade
P/OCF Ratio
7.849.41--77.10-
Upgrade
EV/Sales Ratio
1.751.872.552.332.905.15
Upgrade
EV/EBITDA Ratio
4.3812.69----
Upgrade
EV/EBIT Ratio
4.4813.86----
Upgrade
EV/FCF Ratio
7.1210.67--76.67-
Upgrade
Debt / Equity Ratio
0.7530.40-3.64-6.443.011.15
Upgrade
Debt / EBITDA Ratio
0.573.68----
Upgrade
Debt / FCF Ratio
0.933.18--17.38-
Upgrade
Asset Turnover
1.601.270.920.771.000.84
Upgrade
Inventory Turnover
3.545.492.765.1710.8212.21
Upgrade
Quick Ratio
1.711.881.641.512.211.80
Upgrade
Current Ratio
2.022.131.861.782.432.18
Upgrade
Return on Equity (ROE)
376.09%---699.04%-55.63%-67.72%
Upgrade
Return on Assets (ROA)
39.01%10.75%-10.68%-24.34%-8.77%-14.04%
Upgrade
Return on Capital (ROIC)
61.27%16.92%-17.95%-37.50%-12.50%-22.19%
Upgrade
Return on Capital Employed (ROCE)
87.10%24.00%----
Upgrade
Earnings Yield
18.96%5.90%-9.92%-22.59%-3.95%-5.03%
Upgrade
FCF Yield
12.75%10.61%-2.27%-28.62%1.16%-9.04%
Upgrade
Buyback Yield / Dilution
-2.96%-1.64%-2.07%0.00%-1.03%-0.81%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q